FDA delayed issuing compounding warning letters and did not send drafted warnings -- including to compounders spotlighted since a deadly meningitis outbreak -- because of the lack of a direct agency policy following court decisions, House Energy and Commerce Committee Democrats say in an investigation into FDA's compounding oversight.
source found here
No comments:
Post a Comment